Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of December 2024, with a report date of December 30, 2024. The document primarily announces a corporate governance update regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report of a foreign private issuer focused on a board appointment and does not contain financial statements or performance metrics.
Material Changes
On December 23, 2024, the Board of Directors appointed Mr. Li Haixiang as a director, effective until the next annual general meeting. Mr. Haixiang holds voting and dispositive power over shares held by Epoch Partner Investments Ltd., the Company's controlling shareholder.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The document notes that Mr. Haixiang brings extensive experience in finance, investment, and capital markets, having served as an independent non-executive director at AVO Insurance Company Holding and FUTU Holding Limited, and as the founder of Virtus Inspire Ventures.
Key Facts for Investor Verification
- Mr. Li Haixiang has been appointed to the Board of Directors.
- Mr. Haixiang represents Epoch Partner Investments Ltd., the controlling shareholder.
- The appointment was made on December 23, 2024.
- No financial performance data is included in this specific filing.